Literature DB >> 8777623

Minimally invasive vasectomy.

B A Holt1, A F Higgins.   

Abstract

OBJECTIVE: To evaluate the associated morbidity and patient comfort of the 'minimally invasive, no scalpel' (MINS) vasectomy. PATIENTS AND METHODS: Eighty-nine consecutive patients presenting for vasectomy underwent a MINS procedure. Post-operatively, the pain experienced, recovery time and complication rate were assessed using a postal questionnaire. The questionnaire was also used to assess a group of historical controls who had undergone a vasectomy using a standard technique.
RESULTS: The length of time to recovery was significantly reduced in patients who underwent the MINS vasectomy (P < 0.05) and the pain, bruising, swelling and complication rate were also less than in patients who underwent a standard vasectomy.
CONCLUSIONS: The MINS vasectomy is preferable to a standard technique, reducing both patient morbidity and the complication rate. This is attributable to the minimal dissection and reduced tissue handling required to expose and isolate the vas.

Entities:  

Keywords:  Developed Countries; Diseases; Europe; Family Planning; Male Sterilization; Microsurgery; Northern Europe; Pain; Research Report; Signs And Symptoms; Sterilization, Sexual; Surgery; Treatment; United Kingdom; Vasectomy

Mesh:

Year:  1996        PMID: 8777623     DOI: 10.1046/j.1464-410x.1996.95119.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  3 in total

1.  Minimally invasive vas surgery using a newly designed double-ringed clamp.

Authors:  Hyun Joon Moon
Journal:  World J Urol       Date:  2009-06-19       Impact factor: 4.226

2.  [Vasectomy today: a review of 1,275 vasectomies in 10 years].

Authors:  F Dahm; P Dahm; J Dahm
Journal:  Urologe A       Date:  2003-02-18       Impact factor: 0.639

Review 3.  Vasectomy surgical techniques: a systematic review.

Authors:  Michel Labrecque; Caroline Dufresne; Mark A Barone; Karine St-Hilaire
Journal:  BMC Med       Date:  2004-05-24       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.